Studies Suggest Possible Link Between Lantus and Cancer
Update, from a press release issued by the International Diabetes Federation (June 29):
Statement from the International Diabetes Federation Related to Studies Published in Diabetelogia Suggesting Possible Link Between Insulin Glargine and Cancer
The International Diabetes Federation (IDF) today called for urgent assessment and responses from regulatory authorities into a possible link between the use of insulin glargine (an insulin analogue) and increased risk of cancer based on findings published on 26 June, 2009 in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD).
The online data published in Diabetelogia is based on four studies relating to a possible link between a long-acting insulin analogue, insulin glargine and cancer. According to EASD, the findings are based on evidence from studies in Germany, Sweden, Scotland and the United Kingdom. The studies however, are not conclusive.
The International Diabetes Federation understands the concern about the Diabetelogia study findings but urges the diabetes community to wait for the current scientific information to be released and calls for urgent further scientific studies to be undertaken in other countries.
The International Diabetes Federation stresses that it is important that people needing insulin do not stop taking the drug. IDF cautioned that people with diabetes should see their doctor for advice before considering any change to their treatment.
Original post, June 26:
"Our information is that indeed a study is likely to be published soon raising the possibility of a link between Lantus use and a certain cancer type," Sanford Bernstein analyst Tim Anderson said in a research note.
More details:
http://www.reuters.com/article/euPrivateEquityNews/idUSTRE55P2PM200...
Statement from the International Diabetes Federation Related to Studies Published in Diabetelogia Suggesting Possible Link Between Insulin Glargine and Cancer
The International Diabetes Federation (IDF) today called for urgent assessment and responses from regulatory authorities into a possible link between the use of insulin glargine (an insulin analogue) and increased risk of cancer based on findings published on 26 June, 2009 in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD).
The online data published in Diabetelogia is based on four studies relating to a possible link between a long-acting insulin analogue, insulin glargine and cancer. According to EASD, the findings are based on evidence from studies in Germany, Sweden, Scotland and the United Kingdom. The studies however, are not conclusive.
The International Diabetes Federation understands the concern about the Diabetelogia study findings but urges the diabetes community to wait for the current scientific information to be released and calls for urgent further scientific studies to be undertaken in other countries.
The International Diabetes Federation stresses that it is important that people needing insulin do not stop taking the drug. IDF cautioned that people with diabetes should see their doctor for advice before considering any change to their treatment.
Original post, June 26:
"Our information is that indeed a study is likely to be published soon raising the possibility of a link between Lantus use and a certain cancer type," Sanford Bernstein analyst Tim Anderson said in a research note.
More details:
http://www.reuters.com/article/euPrivateEquityNews/idUSTRE55P2PM200...
Replies are closed for this discussion.
Replies to This Discussion
-
Permalink Reply by John Smith on -
O no! I hope it's not true...I used Lantus from the time it came out until last week :-(
-
Permalink Reply by Robyn on -
Oh great....I was on it since it first came out, up until a few months ago.
-
Permalink Reply by Amanda on -
this is scary. i've been on lantus since it came out too. it works great for me i'd hate to have to switch. another side of me thinks i shouldn't worry because it seems like everything causes cancer or is bad for you in some way or another. maybe this will make my decision to switch to levamir an easier one. i so wish i had money for a pump and wouldn't have to worry about long acting insulin anymore!!
-
Permalink Reply by Robyn on
-
I had heard "rumors" of this many months ago....It made my switch to Levemir alot easier.
-
Permalink Reply by Carol Coombes on -
I too have used Lantus sice dx 2/07. Just what we all need another thing to worry about.
-
Permalink Reply by kerry on -
Hmmm, I had read on a blog somewhere that even well-controlled diabetics are still getting complications, and one possible explanation is that the newer insulins like Lantus do not contain c-peptides, which is theorized to protect against complications.
Now a possible risk of cancer from Lantus and the article mentioned a possibility, maybe down the road, Levemir.
Can you even purchase NPH insulin (pork) anymore?
I think I've seen some tudiabetes members who are on NPH... (I think someone also mentioned taking it at bedtime to help with dawn phenomena)
I wonder if this might end up like the thyroid controversy where so many patients want the old-fashioned Armour thyroid (pork), because it is more similar in structure to human thyroid.
-
Permalink Reply by Jenny on -
NO injectable insulin contains C-peptide.
C-peptide is a byproduct of an intermediate stage of insulin synthesis in the pancreas.
All injected insulins old and new are copies of the final insulin molecule, so the byproduct which breaks off in the intermediate stage can't be there.
-
Permalink Reply by Chandler Jay Nutik on -
Here's an article on WSJ saying that Sanofi is denying any causal link. http://online.wsj.com/article/BT-CO-20090626-714763.html" target="_blank">
-
Permalink Reply by Chandler Jay Nutik on
-
Clearly I don't know how to add a link, but you can copy and paste. It sounds like this is all driven by $.
-
Permalink Reply by Mike Polce on -
Another link that is related to this development: http://philadelphia.injuryboard.com/fda-and-prescription-drugs/poss...
Spread the word
Follow Us
Our Other Programs
 |
 |
 |
 |
 |
Most Popular Pages
- Topics and Videos
- Blood glucose meters
- Average Diabetic Readings
- A1C Readings
- Grams of Carbs per Meal
- Which CGM is more accurate
- Omnipod Review
- Animas Ping or Cozmore
- Famous people with diabetes
- Sugar Free Cheesecake
- iPhone Diabetes Applications
- Online Blood Glucose Tracking tools
- 62 Years Of Type 1 Diabetes
- Diabetes Categories
- Recipes for Diabetics
- Type 2 Diabetes Forum
- Type 1 Diabetes Forum
- Insulin Pumpers Forum
- LADA: Type 1.5 Diabetes Forum
- Diabetes Groups
- Insulin Pumpers Group
- Continuous Glucose Monitor - CGM Users
- Dexcom Continuous Glucose Monitor Users
- Byetta Users Forum
- Raw Food Diabetics
- Deltec Cozmo Insulin Pump Users
- Animas Insulin Pump Users
- Symlin Users Forum
TuDiabetes Team
 Manny Hernandez |
 Andreina Davila |
 MelissaBL |
 Kristin |
 Scott |
 Teena Swager |
Welcome Committee
Content Committee
DHF Ambassadors
© 2009 Created by Diabetes Hands Foundation, P.O. Box 9421, Berkeley, CA 94709.
Diabetes Hands Foundation (DHF) is a 501(c)(3) nonprofit. Donations to DHF are eligible to be deducted.
Disclaimer
The contents of TuDiabetes is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition, including without limitation diabetes. Never disregard professional medical advice or delay in seeking it because of something you have read on TuDiabetes.
If you think you may have a medical emergency, call your doctor or 911 immediately. The Diabetes Hands Foundation does not endorse any specific tests, physicians, products, services, procedures, opinions, or other information that are advertised or mentioned on the web site.
TuDiabetes®, TuDiabetes.org®, Word in Your Hand™, Drawing Diabetes™, Diabetes Supplies Art™ and No-Sugar Added Poetry™ are trademarks or registered trademarks of the Diabetes Hands Foundation.
